Navigation Links
RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
Date:1/13/2009

ss release as a result of new information, future events or otherwise.

About Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs, innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 97,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1) Ohtsu, A et al. Multicenter phase II study of RAD001 for previously treated metastatic gastric cancer. Presented at the American Society of Clinical Oncology's 2009 Gastrointestinal Cancers Symposium, January 15, 2008.

(2) American Cancer Society. Detailed Guide: Stomach Cancer. Available at :

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
2. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
3. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
4. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
5. RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
6. Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
7. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 "Copay ... inflate sales of brand drugs among patients with ... according to a new report  from the ... of the Inspector General (OIG). Federal anti-kickback laws prohibit ... that are subsidized by the federal government. ...
(Date:9/19/2014)... 2014 Research and ... addition of the "Global Gynecological Devices ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... into wide categories based on their operations. ... of different gynecological conditions that affect the ...
(Date:9/19/2014)... -- 4WEB Medical announces the formal launch of the ... on the market today at this weekend,s American ... Chicago .  The Osteotomy Truss System is a ... 74 size options included in one versatile set. Previously ... to 18 implant sizes, which limited a surgeon,s ability ...
Breaking Medicine Technology:PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2
... NEW YORK, Oct. 8 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... increased the size of its previously announced underwritten public ... shares and agreed to an indicative price of $28.00 ... sole book-running manager for the offering. The offering is ...
... Caremark (NYSE: CVS ) is leading the ... issues, with several recently introduced initiatives now set to ... and Chief Operating Officer Larry Merlo and other senior ... in New York City today. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) ...
Cached Medicine Technology:Regeneron Increases Size of Public Offering of Common Stock 2Regeneron Increases Size of Public Offering of Common Stock 3CVS Caremark Ready to Support Patients and Payors Through Coming Era of Health Care Expansion 2CVS Caremark Ready to Support Patients and Payors Through Coming Era of Health Care Expansion 3
(Date:9/21/2014)... 2014 (HealthDay News) -- Young women starting college understand ... foods they should eat. But they aren,t confident they ... to a new study. The study involved ... Illinois,s Peer Education Exercising and Eating Right program. The ... choose to eat if they were very busy with ...
(Date:9/21/2014)... 2014 Discount-Dress.com, a company ... recently announced its decision to implement a new shopping ... for ladies across the world. Furthermore, the company has ... ladies. , The new items come in fashionable ... prices, up to 56 percent off. "We are happy ...
(Date:9/21/2014)... September 21, 2014 Market ... (CAS 49562-28-9) Industry, 2009-2019 is a professional ... Chinese Fenofibrate (CAS 49562-28-9) industry. The report ... (CAS 49562-28-9) including its classification, application and ... China’s top manufacturers of Fenofibrate (CAS 49562-28-9) ...
(Date:9/21/2014)... del Rio, Colorado (PRWEB) September 21, 2014 ... Vail, Colorado, ten teams of disabled and able-bodied athletes ... cycles, and completed a ropes course in pursuit of ... Challenge from national non-profit World T.E.A.M. Sports, disabilities ... participating athletes who successfully completed the three stage event. ...
(Date:9/21/2014)... An experienced review website in the global market, Top10BestSEOHosting.com, ... announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost ... has been a boom in websites in recent years, ... in the number of web hosting companies that offer ... VPS (Virtual Private Server) is the method of partitioning ...
Breaking Medicine News(10 mins):Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2
... KENSINGTON, Md., Sept. 8 The first-ever New Jersey Psoriasis ... 2009, at beautiful Van Saun Park. The walk, to ... Cure Now, will include entertainment, information booths on psoriasis treatments, ... with psoriasis and psoriatic arthritis. Janine Natoli of Little ...
... improves sleep quality in menopausal women with hot flashes, ... in the September issue of the Journal of ... women experience sleep disruption, often in the form of ... study is the first to show sustained benefits in ...
... , Sponsored by Chester County Eye ... WEST CONSHOHOCKEN, Pa., Sept. 8 Chester County Eye Care ... a SupportSight seminar in West Chester on September 26th. ... affected by macular degeneration and for those who would like to learn ...
... , , PITTSBURGH, Sept. 8 ... in toothpaste - new iso-active(R) Foaming Gel. Iso-active has a ... areas of the mouth. , , According to ... much of their tooth surface is actually hidden between the teeth. ...
... , MEXICO CITY, Sept. 8 ... "the Company"), one of the fastest,growing pharmaceutical and personal care ... today revisions to its,earnings guidance for the full year of ... 35%-38% and an EBITDA margin of approximately 25%. , ...
... in place, rates barely budge, report finds , TUESDAY, ... campaigns and widespread agreement about the importance of colorectal ... be screened do so, new research finds. , Rates ... lower still, with only 22 percent of lower-income people ...
Cached Medicine News:Health News:First-Ever NJ Psoriasis Walk Coming to Paramus on Sept. 12 2Health News:Seizure drug enhances sleep for women with hot flashes 2Health News:SupportSight Comes to West Chester, Saturday, September 26th; Free Seminar for Those Affected by Macular Degeneration 2Health News:New Gel Technology Reaches Hidden Areas of the Mouth 2Health News:New Gel Technology Reaches Hidden Areas of the Mouth 3Health News:Genomma Lab Internacional Revises 2009 Earnings Guidance 2Health News:Colon Cancer Screenings Still Too Low: Study 2Health News:Colon Cancer Screenings Still Too Low: Study 3
... The ORTHOSTAR table is the ... today. It was designed for ... body traction with an integrated ... a special purpose operating table ...
... is restricted. Due to its excellent drive ... every situation. For many complicated surgery positions, ... on the JUPITER during the induction to ... the high level of stability of JUPITER ...
... The mobile universal operating table ... table top allows for unlimited C-arm ... comfort for both neurosurgical and cardiovascular ... need for floor support can easily ...
... carbon fiber c-arm table allows 50 ... brachytherapy, gynecology, gastroenterology, cardiovascular, orthopedic, ENT, ... design allows easy access for all ... 16-inch elevating travel, 16-inch longitudinal travel, ...
Medicine Products: